DACOGEN Side Effects

7006396-9 | Myocarditis
on Aug 31, 2010 Male patient from FRANCE , 50 years of age, weighting 286.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: myocarditis. Dacogen dosage: Intravenous. Patient was hospitalized.

6946361-0 | Abdominal Distension, Constipation, Left Ventricular Dysfunction, Lung Infection, Pleural Effusion, Pneumonia, Sepsis, Thrombocytopenia, Urinary Bladder Haemorrhage
Patient was taking Dacogen (View Usage). Patient had the following side effects: abdominal distension, constipation (What is constipation?), left ventricular dysfunction, lung infection, pleural effusion, pneumonia (What is pneumonia?), sepsis (What is sepsis?), thrombocytopenia, urinary bladder haemorrhage on Aug 10, 2010 from UNITED STATES Additional patient health information: Male patient , 89 years of age, was diagnosed with acute myeloid leukaemia and. Dacogen dosage: 20 Mg/m2, 1 In 1 Day, Intravenous. During the same period patient was treated with CYTARABINE (20 Mg/m2, 1 In 1 Day, Subcutaneous) (View Cytarabine Review and Cytarabine Label ).

6938468-9 | Infection, Platelet Count Decreased, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Aug 03, 2010 by a Male patient taking Dacogen (View Usage) (Dosage: 50 Mg, Intravenous Drip) was diagnosed with myelodysplastic syndrome and. Location: CHINA , 51 years of age, After Dacogen was administered, patient had the following side effects: infection (What is infection?), platelet count decreased, red blood cell count decreased, white blood cell count decreased.

6936416-9 | Asthenia, Febrile Neutropenia, Pneumonia, Pulmonary Fibrosis
on Aug 05, 2010 Male patient from UNITED STATES , 45 years of age, weighting 220.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, febrile neutropenia, pneumonia (What is pneumonia?), pulmonary fibrosis (What is pulmonary fibrosis?). Dacogen dosage: Half Dose For Five Days Intravenous. Patient was hospitalized.


6924474-7 | Myocarditis
on Jul 27, 2010 Male patient from FRANCE , 50 years of age, weighting 286.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient had the following side effects: myocarditis. Dacogen dosage: Intravenous. Patient was hospitalized.

6917711-6 | Bone Marrow Failure, Infection
Patient was taking Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: bone marrow failure, infection (What is infection?) on Jul 22, 2010 from CHINA Additional patient health information: Female patient , 69 years of age, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 20 Mg/m2, 1 In 1 Day, Intravenous Drip.

6917663-9 | Infection, Platelet Count Decreased, Red Blood Cell Count, White Blood Cell Count Decreased
Adverse event was reported on Jul 22, 2010 by a Male patient taking Dacogen (View Usage) (Dosage: 50 Mg, Intravenous Drip) was diagnosed with myelodysplastic syndrome and. Location: CHINA , 51 years of age, Patient experienced the following unwanted or unexpected effects: infection (What is infection?), platelet count decreased, red blood cell count, white blood cell count decreased.

6916852-7 | Cardiac Failure, Renal Failure Acute
on Aug 09, 2010 Female patient from UNITED STATES , 71 years of age, weighting 135.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient had the following side effects: cardiac failure, renal failure acute. Dacogen dosage: . Patient was hospitalized.

6916256-7 | Aspergillosis, Asthenia, Chills, Confusional State, Contusion, Coordination Abnormal, Erythema, Febrile Neutropenia, Head Injury
on Jul 21, 2010 Male patient from UNITED STATES , 74 years of age, weighting 211.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: aspergillosis, asthenia, chills, confusional state, contusion, coordination abnormal, erythema, febrile neutropenia, head injury. Dacogen dosage: 20 Mg/m2, Intravenous. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), JANUVIA (View Januvia Review and Januvia Label ). Patient was hospitalized.

6909423-X | Infection, Malignant Neoplasm Progression, Myelodysplastic Syndrome
Patient was taking Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), malignant neoplasm progression, myelodysplastic syndrome on Jul 22, 2010 from CHINA Additional patient health information: Female patient , 31 years of age, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 50 Mg, Intravenous.

6888061-1 | Erythema, Venous Thrombosis
Adverse event was reported on Jul 09, 2010 by a Female patient taking Dacogen (View Usage) (Dosage: 35 Mg, Intravenous (not Otherwise Specified)) was diagnosed with myelodysplastic syndrome and. Location: COLOMBIA , 73 years of age, Patient had the following side effects: erythema, venous thrombosis.

6870154-6 | Conjunctival Haemorrhage, Conjunctival Pallor, Cough, Diarrhoea, Hyperhidrosis, Infection, Vomiting
on Jul 07, 2010 Male patient from CHINA , 82 years of age, weighting 143.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: conjunctival haemorrhage, conjunctival pallor, cough, diarrhoea, hyperhidrosis, infection (What is infection?), vomiting. Dacogen dosage: 50 Mg, 1 In 1 Day, Intravenous. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), MOXIFLOXACIN HYDROCHLIORIDE (MOXIFLOXACIN HYDROCHLORIDE) (View Moxifloxacin Hydrochlioride (moxifloxacin Hydrochloride) Review and Moxifloxacin Hydrochlioride (moxifloxacin Hydrochloride) Label ), PHOSPHATIDYLCHOLINE (PHOSPHATIDYL CHOLINE) (View Phosphatidylcholine (phosphatidyl Choline) Review and Phosphatidylcholine (phosphatidyl Choline) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), TROPISETRON HCL (TROPISETRON HYDROCHLORIDE) (View Tropisetron Hcl (tropisetron Hydrochloride) Review and Tropisetron Hcl (tropisetron Hydrochloride) Label ), ASPISOL (ACETYLSALICYLATE LYSINE) (View Aspisol (acetylsalicylate Lysine) Review and Aspisol (acetylsalicylate Lysine) Label ).

6870153-4 | Cerebral Haemorrhage, Infection
on Jul 07, 2010 Male patient from CHINA , 88 years of age, weighting 134.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, infection (What is infection?). Dacogen dosage: 50 Mg, 1 In 1 Day, Intravenous Drip. During the same period patient was treated with PAMBA (AMINOMETHYLBENZOIC ACID) (View Pamba (aminomethylbenzoic Acid) Review and Pamba (aminomethylbenzoic Acid) Label ), CEFMETAZOLE SODIUM (CEFMETAZOLE SODIUM) (View Cefmetazole Sodium (cefmetazole Sodium) Review and Cefmetazole Sodium (cefmetazole Sodium) Label ). Patient was hospitalized.

6838299-4 | Arthralgia, Haemoglobin Decreased, Joint Swelling, Neutrophil Count Decreased, Osteoarthritis, Platelet Count Decreased, Pyrexia, White Blood Cell Count Decreased
Patient was taking Dacogen (View Usage). Patient had the following side effects: arthralgia, haemoglobin decreased, joint swelling, neutrophil count decreased, osteoarthritis (What is osteoarthritis?), platelet count decreased, pyrexia, white blood cell count decreased on Jun 23, 2010 from CHINA Additional patient health information: Female patient , 54 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 22.5 Mg, 1 In 8 Hours, Intravenous; Cyce 2.

6836854-9 | Acute Myeloid Leukaemia, Malignant Neoplasm Progression
Adverse event was reported on Jun 28, 2010 by a Male patient taking Dacogen (View Usage) (Dosage: 35 Mg, Intravenous) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 70 years of age, weighting 161.0 lb, After Dacogen was administered, patient had the following side effects: acute myeloid leukaemia, malignant neoplasm progression.

6818840-8 | Cardiac Failure, Pulmonary Oedema, Transfusion Reaction
on Jun 23, 2010 Female patient from COLOMBIA , 57 years of age, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, pulmonary oedema, transfusion reaction. Dacogen dosage: 20 Mg/kg, In 5 Day, Intravenous.

6818769-5 |
on Jun 12, 2010 Male patient from UNITED STATES , 70 years of age, was treated with Dacogen (View Usage). . Dacogen dosage: 1 Cycle Intravenous.

6811511-3 | Arthralgia, Haemoglobin Decreased, Joint Swelling, Neutrophil Count Decreased, Osteoarthritis, Platelet Count Decreased, Pyrexia, White Blood Cell Count Decreased
Patient was taking Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: arthralgia, haemoglobin decreased, joint swelling, neutrophil count decreased, osteoarthritis (What is osteoarthritis?), platelet count decreased, pyrexia, white blood cell count decreased on Jun 12, 2010 from CHINA Additional patient health information: Female patient , 54 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 22.5 Mg, 1 In 8 Hour, Intravenous Cycle 2. Patient was hospitalized.

6769532-5 | Arthralgia, Joint Swelling, Pyrexia
Adverse event was reported on May 24, 2010 by a Female patient taking Dacogen (View Usage) (Dosage: 22.5 Mg, 1 In 8 Hour, Intravenous) was diagnosed with myelodysplastic syndrome and. Location: CHINA , 54 years of age, weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, joint swelling, pyrexia.

6727773-7 | Renal Failure
on Apr 28, 2010 Male patient from PERU , 72 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Dacogen (View Usage). Patient had the following side effects: renal failure. Dacogen dosage: 3 Dose(s) In 1 Total, Intravenous.

6700616-3 | Brain Oedema, Cerebral Haemorrhage, Disease Progression, Eye Pain
on Apr 19, 2010 Male patient from UKRAINE , 46 years of age, was diagnosed with chronic myelomonocytic leukaemia, thrombocytopenia and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: brain oedema, cerebral haemorrhage, disease progression, eye pain. Dacogen dosage: 15 Mg/m2, 1 In 8 Hour, Intravenous. During the same period patient was treated with DICYNONE (ETAMSILATE) (20 Mg/kg, In 3 Day) (View Dicynone (etamsilate) Review and Dicynone (etamsilate) Label ).

6696219-X | Parotitis
Patient was taking Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: parotitis on Apr 07, 2010 from BRAZIL Additional patient health information: Female patient , 65 years of age, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 20 Mg, 1 In 1 Day.

6688796-X | Infection
Adverse event was reported on Mar 30, 2010 by a Male patient taking Dacogen (View Usage) (Dosage: 35 Mg, In 1 Day, Intravenous) was diagnosed with myelodysplastic syndrome and. Location: CHINA , 78 years of age, Patient had the following side effects: infection (What is infection?).

6673802-9 | Neck Mass
on Mar 23, 2010 Male patient from CHINA , 70 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: neck mass. Dacogen dosage: Intravenous; 20 Mg, 1 In 1 Day, Intravenous.

6662559-3 | Infection
on Mar 12, 2010 Male patient from CHINA , 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?). Dacogen dosage: 35 Mg, 4 In 1 Day, Intravenous.

6653899-2 | Arrhythmia
Patient was taking Dacogen (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?) on Mar 09, 2010 from CHINA Additional patient health information: Male patient , 86 years of age, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 20 Mg/m2, Intravenous.

6651774-0 | Cerebral Infarction
Adverse event was reported on Mar 10, 2010 by a Female patient taking Dacogen (View Usage) (Dosage: 25 Mg/m2, Intravenous) was diagnosed with myelodysplastic syndrome and. Location: CHINA , 76 years of age, weighting 127.9 lb, After Dacogen was administered, patient had the following side effects: cerebral infarction.

6638140-9 | Abdominal Distension, Constipation, Left Ventricular Dysfunction, Lung Infection, Pleural Effusion, Pneumonia, Thrombocytopenia, Urinary Bladder Haemorrhage, Urinary Retention
on Mar 02, 2010 Male patient from UNITED STATES , 89 years of age, was diagnosed with acute myeloid leukaemia and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, constipation (What is constipation?), left ventricular dysfunction, lung infection, pleural effusion, pneumonia (What is pneumonia?), thrombocytopenia, urinary bladder haemorrhage, urinary retention. Dacogen dosage: 20 Mg/m2, 1 In 1 Day, Intravenous. Patient was hospitalized.

6587751-8 | Pancytopenia
on Feb 17, 2010 Male patient from UNITED STATES , 69 years of age, was treated with Dacogen (View Usage). Patient had the following side effects: pancytopenia. Dacogen dosage: Q28days Iv. During the same period patient was treated with CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), FOLVITE (View Folvite Review and Folvite Label ), MIRALAX (View Miralax Review and Miralax Label ), ANZEMET (View Anzemet Review and Anzemet Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), LASIX (View Lasix Review and Lasix Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

6556561-X | Cough, Febrile Neutropenia, Haemoglobin Decreased, Liver Abscess, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: cough, febrile neutropenia, haemoglobin decreased, liver abscess, platelet count decreased, white blood cell count decreased on Jan 15, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 61 years of age, weighting 110.2 lb, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 30 Mg, 1 In 1 Day, Intravenous. Patient was hospitalized.

6529053-1 | Polyneuropathy
Adverse event was reported on Dec 11, 2009 by a Female patient taking Dacogen (View Usage) (Dosage: 45 Mg/m2, In 1 Month, Intravenous; 50 Mg, In 1 Month, Intravenous) was diagnosed with myelodysplastic syndrome and. Location: URUGUAY , 51 years of age, Patient experienced the following unwanted or unexpected effects: polyneuropathy.

6529000-2 | Infection, Multi-organ Failure
on Dec 17, 2009 Male patient from CHINA , 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient had the following side effects: infection (What is infection?), multi-organ failure. Dacogen dosage: 50 Mg, Intravenous.

6528760-4 | Dysuria, Eating Disorder, Lung Infection
on Dec 09, 2009 Male patient from CHINA , 59 years of age, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: dysuria, eating disorder (What is eating disorder?), lung infection. Dacogen dosage: 50 Mg, Intravenous.

6502466-X | Dysuria, Hypophagia, Pyrexia
Patient was taking Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria, hypophagia, pyrexia on Nov 27, 2009 from CHINA Additional patient health information: Male patient , 59 years of age, was diagnosed with myelodysplastic syndrome and. Dacogen dosage: 50 Mg, Intravenous; 50 Mg Intravenous.

6468233-0 | Liver Abscess, Pneumonia
Adverse event was reported on Nov 16, 2009 by a Male patient taking Dacogen (View Usage) (Dosage: 20 Mg/m2, Intravenous; 20 Mg/m2, Intravenous; 20 Mg/m2, Intravenous) was diagnosed with myelodysplastic syndrome and. Location: MALAYSIA , 56 years of age, Patient had the following side effects: liver abscess, pneumonia (What is pneumonia?).

6457226-5 | Bone Marrow Failure, Graft Versus Host Disease
on Nov 04, 2009 Male patient from UNITED STATES , 61 years of age, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: bone marrow failure, graft versus host disease. Dacogen dosage: Mg/m2, 1 In 1 Day, Intravenous.

6416238-8 | Off Label Use, Peritonitis, Somnolence
on Oct 07, 2009 Female patient from NETHERLANDS , 23 years of age, was diagnosed with acute myeloid leukaemia and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, peritonitis, somnolence. Dacogen dosage: 250 Mg/m2, 2 In 1 Day, Intravenous.

6416229-7 | Hemiparesis, Off Label Use, Peritonitis, Somnolence
Patient was taking Dacogen (View Usage). Patient had the following side effects: hemiparesis, off label use, peritonitis, somnolence on Oct 07, 2009 from NETHERLANDS Additional patient health information: Female patient , 48 years of age, was diagnosed with acute myeloid leukaemia and. Dacogen dosage: 500 Mg/m2, 2 In 1 Day, Intravenous.

6416195-4 | Off Label Use, Peritonitis
Adverse event was reported on Oct 07, 2009 by a Male patient taking Dacogen (View Usage) (Dosage: 125 Mg/m2, 2 In 1 Day, Intravenous) was diagnosed with acute myeloid leukaemia and. Location: NETHERLANDS , 61 years of age, After Dacogen was administered, patient had the following side effects: off label use, peritonitis.

6416192-9 | Hemiparesis, Off Label Use, Peritonitis, Somnolence
on Oct 07, 2009 Female patient from NETHERLANDS , 56 years of age, was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: hemiparesis, off label use, peritonitis, somnolence. Dacogen dosage: 250 Mg/m2, Intravenous.

6416168-1 | Off Label Use, Peritonitis
on Oct 07, 2009 Male patient from NETHERLANDS , 51 years of age, was diagnosed with acute myeloid leukaemia and was treated with Dacogen (View Usage). Patient had the following side effects: off label use, peritonitis. Dacogen dosage: 125 Mg/m2, 2 In 1 Day, Intravenous.

6416166-8 | Off Label Use, Peritonitis
Patient was taking Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: off label use, peritonitis on Oct 07, 2009 from NETHERLANDS Additional patient health information: Male patient , 45 years of age, was diagnosed with acute lymphocytic leukaemia and. Dacogen dosage: 125 Mg/m2, 2 In 1 Day, Intravenous.

6415705-0 | Peritonitis
Adverse event was reported on Oct 07, 2009 by a Male patient taking Dacogen (View Usage) (Dosage: 125 Mg/m2, 2 In 1 Day, Intravenous) was diagnosed with acute myeloid leukaemia and. Location: NETHERLANDS , 61 years of age, Patient experienced the following unwanted or unexpected effects: peritonitis.

6415693-7 | Peritonitis
on Oct 07, 2009 Male patient from NETHERLANDS , 45 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Dacogen (View Usage). Patient had the following side effects: peritonitis. Dacogen dosage: 125 Mg/m2, 2 In 1 Day, Intravenous.

6415692-5 | Hemiparesis, Peritonitis, Somnolence
on Oct 07, 2009 Female patient from NETHERLANDS , 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: hemiparesis, peritonitis, somnolence. Dacogen dosage: 125 Mg/m2, 2 In 1 Day, Intravenous.

6415686-X | Peritonitis
Patient was taking Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: peritonitis on Oct 07, 2009 from NETHERLANDS Additional patient health information: Male patient , 51 years of age, was diagnosed with acute myeloid leukaemia and. Dacogen dosage: 125 Mg/m2, 2 In 1 Day, Intravenous.

6415679-2 | Hemiparesis, Off Label Use, Peritonitis, Somnolence
Adverse event was reported on Oct 07, 2009 by a Female patient taking Dacogen (View Usage) (Dosage: 250 Mg/m2, 2 In 1 Day, Intravenous) was diagnosed with acute myeloid leukaemia and. Location: NETHERLANDS , 56 years of age, Patient had the following side effects: hemiparesis, off label use, peritonitis, somnolence.

6408880-5 | Bone Marrow Failure, Cerebral Haemorrhage, Cerebral Infarction, Intestinal Infarction, Renal Infarct, Splenic Infarction, Thrombotic Thrombocytopenic Purpura
on Sep 24, 2009 Female patient from UNITED STATES , 64 years of age, weighting 143.3 lb, was diagnosed with refractory anaemia and was treated with Dacogen (View Usage). After Dacogen was administered, patient had the following side effects: bone marrow failure, cerebral haemorrhage, cerebral infarction, intestinal infarction, renal infarct, splenic infarction, thrombotic thrombocytopenic purpura. Dacogen dosage: Intravenous : 20 Mg/m2, Intravenous. Patient was hospitalized.

6381974-9 | Pneumonia
on Sep 11, 2009 Female patient from UNITED STATES , 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Dacogen (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Dacogen dosage: Cycle 1 Intravenous, Cycle 2. Patient was hospitalized.

6367510-1 | Aplasia, Asthenia, Cerebral Haemorrhage, Cerebral Infarction, Intestinal Infarction, Renal Infarct, Splenic Infarction, Thrombotic Thrombocytopenic Purpura
Patient was taking Dacogen (View Usage). Patient had the following side effects: aplasia, asthenia, cerebral haemorrhage, cerebral infarction, intestinal infarction, renal infarct, splenic infarction, thrombotic thrombocytopenic purpura on Sep 08, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 143.3 lb, was diagnosed with refractory anaemia and. Dacogen dosage: Cycle #1 Intravenous. Patient was hospitalized.